Skip to content

Frequency Foundation

Twice the Energy with Half the Stress

Addressing the evolved COVID Flu

As we step into 2025, the Frequency Research Foundation continues to address the evolving challenges posed by the evolved COVID Flu. Originally detected in early 2023, this formidable pathogen has not only persisted but also adapted, significantly impacting individuals and environments worldwide.

The Evolution from 2023 to Present

The journey of this COVID flu began over a year ago when we first encountered its complex nature. Initially resembling typical flu variants, it soon revealed a broader spectrum of associated pathogens, including viruses, bacteria, and parasites. This complexity often caused prolonged illnesses, lasting several months without comprehensive frequency treatment to eliminate all underlying pathogens.

In November 2024 we found a significantly evolved version of this flu in a few clients in the United States. Coming into January 2025 it has spread to our European clients. Stealth COVID variants were found that cripple the mitochondria and sap all energy from the body. Some bacterial pathogens are causing severe swelling of glands and lymph nodes. Multiple parasites host the flu pathogens and until they are all eliminated the flu repeats itself through internal reinfection. It is highly contagious and it is easy to get reinfected from external exposure to buildings or people who carry the flu.

Understanding the Complex Syndrome

Today’s COVID flu transcends typical respiratory infections by embedding itself into our surroundings, infecting buildings and other indoor environments, making eradication particularly challenging. The persistence of this flu is partly due to airborne parasites that act as vectors, carrying the pathogen across various environments and thus facilitating continued cycles of infection and reinfection.

Breakthroughs in Frequency Research

One groundbreaking discovery involved a client who experienced repeated infections triggered by physical activity. Investigations revealed that certain parasites were releasing flu pathogens during exertion. By targeting these parasites with specific frequencies, we successfully halted the reinfection process, underscoring the nuanced approach needed for this flu variant.

Check out our podcast on these disruptive innovations!

Providing Free Access to Frequency Sets

In line with our commitment to public health, the Frequency Research Foundation offers free access to advanced frequency sets, significantly enhanced by AI for increased effectiveness. These sets are designed to target a wide range of pathogens identified in the ongoing COVID flu crisis, including:

  • Multiple SARS-CoV-2 variants
  • Parasites like Giardia
  • Various bacteria and viruses responsible for respiratory infections
  • Newly identified pathogens contributing to the syndrome’s complexity

Refining Our Approach

Our frequency sets are continuously updated with the latest data from global DNA sequencing efforts, ensuring that our interventions are both swift and precise. This proactive approach is vital in managing such a dynamic and persistent health threat.

Beyond Traditional Prevention Methods

Previous strategies such as mask-wearing and standard sanitization proved insufficient against the multifaceted nature of the current COVID flu. Our comprehensive strategy now includes regular environmental screenings and targeted frequency treatments, aiming to break the cycle of reinfection effectively.

Fostering Global Collaboration

By freely sharing our frequency sets and providing comprehensive support through our clinics, we encourage a unified global response to this health crisis. This collaborative effort is essential for refining treatment methods and expediting recovery on a worldwide scale.

As we face this evolved health threat, the Frequency Research Foundation remains dedicated to advancing frequency-based therapies. We continue to explore innovative solutions to tackle this complex challenge and invite further collaboration to enhance global health resilience.

Interested in learning more?

Navigating the FLIRT Strain of COVID-19: What You Need to Know

Understanding the FLIRT Strain COVID-19 is critical as we face new challenges in the ongoing pandemic. This strain, emerging from the Omicron variant, exhibits unique mutations that could influence transmission and vaccine efficacy. Here, we delve into the characteristics of FLIRT, its potential impact on public health, and how Frequency Research Foundation is responding with innovative frequency therapies.

Emergence and Impact of FLIRT Variants

Initially detected in early 2024, the FLIRT variants have swiftly gained prominence, particularly the KP.2 strain, which, by May, had become dominant in the U.S. This strain, representing a significant percentage of new infections, indicates a possible advantage in both transmission and immune evasion, raising concerns about its potential impact on public health efforts.

Symptoms and Immune Response

The symptoms associated with the FLIRT variants are similar to those observed with other Omicron subvariants, including respiratory symptoms like a runny nose and sore throat, as well as systemic symptoms like fatigue. However, the FLIRT strains have shown a capacity to partially evade immune responses, which is concerning for populations without prior immunity or those who are immunocompromised.

Transmission Characteristics and Public Health Response

The FLIRT variants exhibit a worrying trend of immune evasion, which could undermine the effectiveness of existing vaccines. Public health authorities are closely monitoring these variants through methods like wastewater surveillance to gauge their spread and impact. This ongoing surveillance is crucial for adapting public health strategies in real-time to mitigate the spread of these variants.

Advanced Solutions from Frequency Research Foundation

At the Frequency Research Foundation, we’re actively developing solutions to address the challenges posed by the FLIRT strain COVID-19. Our approach includes:

  1. Targeted Research: Continuous analysis and integration of the latest scientific data on FLIRT variants to refine our frequency therapies.
  2. Innovative Treatment Options: Utilizing advanced technologies, including AI-enhanced photoanalysis, to identify and develop effective frequency sets tailored to combat these specific strains.
  3. Remote Accessibility: Ensuring our treatments are accessible globally through our advanced remote frequency transmission technology, allowing patients worldwide to receive effective care without the need for in-person visits.

Navigating the complexities of the FLIRT variants demands innovative and adaptable solutions. At Frequency Research Foundation, we leverage advanced science to develop effective frequency treatments, available through our detailed COVID-19 frequency set offerings.

Learn More and Act

For more information on our pioneering frequency treatments and to access targeted solutions for the FLIRT variant and other COVID strains, visit our COVID-19 Frequency Sets page.

COVID Accelerated Aging Solutions: Reversing Pandemic’s Hidden Impacts

As we address “COVID Accelerated Aging Solutions,” it’s crucial to understand the pandemic’s ongoing impact on our biological clocks. At Frequency Research Foundation, our specialized clinics provide effective treatments to reverse the aging effects accelerated by COVID-19, focusing on our PhotoAnalysis Remote Rife Clinic and the Reverse Aging Program. Explore this topic further by listening to our Spotify Podcast here.

The Alarming Link Between COVID-19 and Accelerated Aging

Recent research underscores the profound long-term effects of COVID-19, revealing that the virus does more than affect immediate respiratory health—it also expedites the aging process. Harvard Medical School’s findings are particularly telling, with severe COVID-19 cases showing brain changes akin to accelerated aging. These results indicate that COVID-19 can induce premature aging in the brain, especially in those with severe symptoms. Further insights can be explored here.

Epigenetic alterations due to COVID-19 are shown to accelerate biological aging by changing DNA methylation patterns. These changes, particularly in genes associated with inflammation and cellular senescence, suggest long-term alterations to the body’s aging mechanisms. The detailed study is available here.

Moreover, research from Houston Methodist provides evidence that COVID-19 can lead to irreversible neurological damage, such as microbleeds and lesions, typically seen in neurodegenerative diseases like Alzheimer’s. This highlights the urgent need for strategies to mitigate neurological and cognitive decline linked to the virus. More details can be found here.

Proactive Detection and Treatment at Frequency Research Foundation

Our PhotoAnalysis Remote Rife Clinic is crucial in detecting low-level COVID infections early. By identifying these infections swiftly, we can intervene before they significantly contribute to premature aging and exacerbate chronic diseases.

The Reverse Aging Program: A Strategic Response

Our Reverse Aging Program directly targets and mitigates the accelerated aging processes induced by COVID-19. Tailored to each client, this program uses advanced treatments and personalized care strategies to significantly improve health outcomes and reduce age-related disease prevalence.

Ready to reverse the aging effects of COVID-19? Visit our PhotoAnalysis Remote Rife Clinic and Reverse Aging Program pages to learn more and sign up today. Our expert team is ready to help you restore your health and vitality.

At Frequency Research Foundation, we are dedicated to combating the accelerated aging effects of COVID-19 with cutting-edge solutions. Join us in our mission to restore youth and health in the post-COVID era. Discover our COVID Accelerated Aging Solutions. Frequency Research Foundation offers treatments to reverse aging effects and improve longevity.

Combating COVID Flu and ACIRD in Humans and Pets: Frequency Research Foundation’s Approach

At the Frequency Research Foundation, our commitment to addressing global health crises has led us to a significant discovery in the fight against COVID flu. Not only have we identified the complex nature of multiple COVID flu strains circulating globally, but we have also recognized their impact across species, including a notable strain known as ACIRD in dogs. This understanding has propelled our efforts to develop remote, non-invasive technologies aimed at combating these infections in humans, animals, and even the spaces we inhabit.

Understanding the Multi-Faceted Nature of COVID Flu

COVID flu complexes identified by Frequency Research Foundation exhibit intricate and varied pathogenic profiles, spread through airborne parasites. Unlike traditional flu strains that target individuals, the February 2023 COVID flu can infiltrate entire ecosystems, infecting canines with ACIRD and posing risks to human family members and their surroundings. This flu spreads through multiple strains of the ancylostoma parasite in aerosol form, persisting not only within lung tissues but also on surfaces and within building ventilation systems.

Our Comprehensive Treatment Approach

Given the extensive nature of these infections, a comprehensive treatment approach is essential. Frequency Research Foundation has taken a significant step by offering a set of frequencies designed to combat the February 2023 COVID flu, now available for free to the public. These frequencies are intended for use in treating individuals, animals afflicted with ACIRD, and sanitizing the spaces they occupy. This holistic approach recognizes the interconnectedness of human and animal health with their living environments.

The Urgency of Environmental Decontamination

The revelation that the February 2023 COVID flu can infiltrate buildings underscores the critical need for environmental decontamination. The Foundation’s initiative to provide frequencies for building treatment is crucial in curbing the disease’s spread. By addressing the infectious threat at all levels – personal, animal, and environmental – we can hope to mitigate the impact of the COVID flu and protect entire communities.

Moving Forward with Frequency-Based Health Innovations

The discovery of multiple circulating COVID flu strains emphasizes the need for ongoing vigilance and innovation in health sciences. Frequency Research Foundation’s efforts represent a vital resource in addressing this global health challenge. As we confront the realities of the COVID flu, the Foundation’s work becomes increasingly crucial. By leveraging frequencies to treat the complex web of pathogens associated with the COVID flu, we open the door to more effective health solutions for our interconnected world.

Navigating the Persistent Waves of COVID Flu: Insights from Frequency Research Foundation

Upadate: The COVID Flu from Feb 2023 has evolved into a full blown syndrome affecting dogs (ACRID) as well as people and buildings. Circulating for more than a year now it is very infectious and persistent. Multiple researches have helped to expand its already large frequency set by identifying new organisms DNA sequenced in government databases.

As 2023 unfolded, we at the Frequency Research Foundation witnessed a recurring global health challenge – the COVID flu. Our extensive client base, spread across the globe, becomes a real-time map tracing the rapid spread of flu viruses. Unlike seasonal flus, the COVID flus of 2023, robust and persistent, are not bound by weather or season. They bring with them a cocktail of pathogens – flu viruses, multiple strains of COVID, and a variety of parasites, bacteria, fungi, and even mycoplasma.

A Year-Long Battle Against a Formidable Foe

Our encounters with these flus have shown that they are not fleeting; they linger for weeks, sometimes months. In one extraordinary case, we observed flu symptoms persisting for a full year until frequencies successfully eliminated them. This enduring presence challenges the conventional understanding of flu and its treatment.

Unlocking the Secret of Stubborn Flus

Twenty years of research have shed light on the tenacious nature of flu. Frequencies, with their inherent precision and reliability, have revealed that it’s not just a single virus at play. We’ve discovered that an airborne parasite, alarmingly infectious, is the vector transporting these pathogens. This large parasite has the unique ability to infect people, animals, and even buildings.

The Swine Flu epidemic was a stark manifestation of this phenomenon, with airports becoming super-spreaders. Since standard flu treatments target only the virus, the actual flu persists until the parasitic vectors die naturally – which takes much longer than anticipated.

A Proactive Approach to a Global Health Menace

When someone approaches us with flu symptoms, our priority is to identify all associated organisms. As we treat more cases, our database grows, leading to a more comprehensive set of frequencies that can potentially conquer the flu in mere days.

Boiron’s Oscillicoccinum 200, a homeopathic remedy, has proven to be an effective adjunct, facilitating the rapid elimination of flu organisms when combined with our frequency treatments at the onset of symptoms.

The Pervasive Threat of COVID Flus

The COVID flus stand out in their infectiousness. Simple activities, like a visit to Starbucks or a routine medical checkup, can result in multiple reinfections. Recognizing the public health crisis at hand, we’ve decided to release these frequencies free of charge to support experienced Rife practitioners. For those who are new to this, our Photoanalysis Remote Rife Clinic stands ready to assist you, your animals, and even sanitize your living spaces from the COVID flu, with the goal of achieving this ideally within a day, barring complications from co-infections.

Masking Up: A Double-Edged Sword

Our research indicates that while masks might not be the ultimate barrier against viruses due to their minuscule size, they do offer protection against the larger organisms responsible for spreading the flu. Data from the period of 2020-2022 align with our findings, as mask-wearing did not significantly impact the spread of COVID but did contribute to a substantial decline in traditional flu cases.

Conclusion

As we continue to navigate the waves of the COVID flu, the Frequency Research Foundation remains dedicated to providing innovative solutions that are validated by two decades of unwavering research. We urge the scientific community to examine our work with an open mind and welcome the opportunity to collaborate in advancing the understanding of frequency-based therapies.

Long COVID – at least 65M people worldwide

Long COVID: major findings, mechanisms and recommendations
Hannah E. Davis, Lisa McCorkell, Julia Moore Vogel & Eric J. Topol 

nature reviews microbiology https://doi.org/10.1038/s41579-022-00846-2

Abstract
Long COVID is an often debilitating illness that occurs in at least 10%
of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infections. More than 200 symptoms have been identifed with impacts
on multiple organ systems. At least 65 million individuals worldwide are
estimated to have long COVID, with cases increasing daily. Biomedical
research has made substantial progress in identifying various
pathophysiological changes and risk factors and in characterizing
the illness; further, similarities with other viral-onset illnesses such as
myalgic encephalomyelitis/chronic fatigue syndrome and postural
orthostatic tachycardia syndrome have laid the groundwork for
research in the feld. In this Review, we explore the current literature
and highlight key fndings, the overlap with other conditions, the
variable onset of symptoms, long COVID in children and the impact of
vaccinations. Although these key fndings are critical to understanding
long COVID, current diagnostic and treatment options are insufcient,
and clinical trials must be prioritized that address leading hypotheses.
Additionally, to strengthen long COVID research, future studies must
account for biases and SARS-CoV-2 testing issues, build on viral-onset
research, be inclusive of marginalized populations and meaningfully
engage patients throughout the research process.

Many of the clients we work with in our Photoanalysis Remote Rife Frequency Clinic have long COVID.

COVID-19 Vaccine Injury, Syndrome Not a Disease: FLCCC Conference Shares How to Treat It

The complex myriad of symptoms in people suspecting of COVID-19 vaccine injury has been given a new name and an extensive treatment protocol:

“Post-COVID-19 vaccines syndrome,” said Dr. Paul Marik, co-founder and Chief Science Officer of the Frontline COVID-19 Critical Care Alliance (FLCCC), on Oct. 15 at a conference in Orlando, Florida, aimed at education and sharing information on treating spike protein-induced health issues.

The Photoanalysis Remote Rife Clinic is specifically designed to help people with the multiple syndromes associated with COVID-19 and long COVID aftereffects. We were recently asked to work with an 86 year old women who went to emergency care and was told she could not come into the building and needed to wait outside on a park bench in sub-freezing weather. After an extended period of waiting with no-one showing up to help her she left. It is not a good idea to depend on a system that is crumbling and failing to help patients.

The SARS-CoV-2 Spike Protein is vulnerable to moderate electric fields

March 2021
License CC BY 4.0 - download PDF
Claudia ArbeitmanClaudia ArbeitmanPablo RojasPedro A Ojeda-MayPedro A Ojeda-May Martin Garcia

ABSTRACT: Most of the ongoing projects aimed at the development of specific therapies and vaccines against COVID-19 use the SARS-CoV-2 spike (S) protein as the main target [1-3]. The binding of the spike protein with the ACE2 receptor (ACE2) of the host cell constitutes the first and key step for virus entry. During this process, the receptor binding domain (RBD) of the S protein plays an essential role, since it contains the receptor binding motif (RBM), responsible for the docking to the receptor. So far, mostly biochemical methods are being tested in order to prevent binding of the virus to ACE2 [4]. Here we show, with the help of atomistic simulations, that external electric fields of easily achievable and moderate strengths can dramatically destabilise the S protein, inducing long-lasting structural damage. One striking field-induced conformational change occurs at the level of the recognition loop L3 of the RBD where two parallel beta sheets, believed to be responsible for a high affinity to ACE2 [5], undergo a change into an unstructured coil, which exhibits almost no binding possibilities to the ACE2 receptor (Figure 1a). Remarkably, while the structural flexibility of S allows the virus to improve its probability of entering the cell, it is also the origin of the surprising vulnerability of S upon application of electric fields of strengths at least two orders of magnitude smaller than those required for damaging most proteins. Our findings suggest the existence of a clean physical method to weaken the SARS-CoV-2 virus without further biochemical processing. Moreover, the effect could be used for infection prevention purposes and also to develop technologies for in-vitro structural manipulation of S. Since the method is largely unspecific, it can be suitable for application to mutations in S, to other proteins of SARS-CoV-2 and in general to membrane proteins of other virus types.

Magnetex – Adjuvant Therapy for COVID Damage

Application of Rotating Magnetic Fields Increase the Activity of Antimicrobials Against Wound Biofilm Pathogens

Scientific Reports volume 8, Article number: 167 (2018) Cite this article

Abstract

Infective complications are a major factor contributing to wound chronicity and can be associated with significant morbidity or mortality. Wound bacteria are protected in biofilm communities and are highly resistant to immune system components and to antimicrobials used in wound therapy.

——–

COVID spikes have been developed in bioweapons labs and research centers in many parts of the world. Forensic analysis shows hundreds of patents over the last several decades along with many hundreds of research papers. For example, Nature Biotechnology maps the network of patents directly related to COVID vaccines.

The coronavirus spike causes significant damage to arteries along with opportunistic infections that cause immediate and long term COVID effects. With the addition of the vaccine there are even more spikes along with coagulation of the blood with can cause blood clots.

Black veins in legs that can be cleared up with Magnetex.

Frequencies can disrupt the spike proteins and associated pathogens. However, many infected individuals present with aches and pain all over the body, COVID rashes, inflamed varicose veins, COVID toes, heart disease, brain aneurisms, and so forth. Rotating magnetic fields along with vibration applied to infected areas can accelerate the destruction of spike proteins, flush out associated pathogens and biofilms and loosen up coagulated blood.

The Magnetex,org product has been useful in conjuction with frequencies assisting in long term COVID problems, particular for paint in joints and in the back, COVID rashes, and inflamed varicose veins. It is a research device so it must be used as instructed by the vendor and use is at your own risk.

COVID-19 Vaccine Boosters for Young Adults: A Risk-Benefit Assessment and Five Ethical Arguments against Mandates at Universities

50 Pages Posted: 12 Sep 2022

Kevin Bardosh

University of Washington; University of Edinburgh – Edinburgh Medical School

Allison Krug

Artemis Biomedical Communications LLC

Euzebiusz Jamrozik

University of Oxford

Trudo Lemmens

University of Toronto – Faculty of Law

Salmaan Keshavjee

Harvard University – Harvard Medical School

Vinay Prasad

University of California, San Francisco (UCSF)

Martin A. Makary

Johns Hopkins University – Department of Surgery

Stefan Baral

John Hopkins University

Tracy Beth Høeg

Florida Department of Health; Sierra Nevada Memorial Hospital

Date Written: August 31, 2022

Abstract

Students at North American universities risk disenrollment due to third dose COVID-19 vaccine mandates. We present a risk-benefit assessment of boosters in this age group and provide five ethical arguments against mandates. We estimate that 22,000 – 30,000 previously uninfected adults aged 18-29 must be boosted with an mRNA vaccine to prevent one COVID-19 hospitalisation. Using CDC and sponsor-reported adverse event data, we find that booster mandates may cause a net expected harm: per COVID-19 hospitalisation prevented in previously uninfected young adults, we anticipate 18 to 98 serious adverse events, including 1.7 to 3.0 booster-associated myocarditis cases in males, and 1,373 to 3,234 cases of grade ≥3 reactogenicity which interferes with daily activities. Given the high prevalence of post-infection immunity, this risk-benefit profile is even less favourable. University booster mandates are unethical because: 1) no formal risk-benefit assessment exists for this age group; 2) vaccine mandates may result in a net expected harm to individual young people; 3) mandates are not proportionate: expected harms are not outweighed by public health benefits given the modest and transient effectiveness of vaccines against transmission; 4) US mandates violate the reciprocity principle because rare serious vaccine-related harms will not be reliably compensated due to gaps in current vaccine injury schemes; and 5) mandates create wider social harms. We consider counter-arguments such as a desire for socialisation and safety and show that such arguments lack scientific and/or ethical support. Finally, we discuss the relevance of our analysis for current 2-dose CCOVIDovid-19 vaccine mandates in North America.

Note: Funding: This paper was partially supported by a Wellcome Trust Society and Ethics fellowship awarded to KB (10892/B/15/ZE) and Wellcome Trust grants to EJ (216355, 221719, 203132).
Competing Interest Statement: We do not have any competing interests to declare.

Keywords: COVID-19 vaccines, mandates, ethics, young adults, risk-benefit analysis

Suggested Citation:

Bardosh, Kevin and Krug, Allison and Jamrozik, Euzebiusz and Lemmens, Trudo and Keshavjee, Salmaan and Prasad, Vinay and Makary, Martin A. and Baral, Stefan and Høeg, Tracy Beth, COVID-19 Vaccine Boosters for Young Adults: A Risk-Benefit Assessment and Five Ethical Arguments against Mandates at Universities (August 31, 2022). Available at SSRN: https://ssrn.com/abstract=4206070 or http://dx.doi.org/10.2139/ssrn.4206070